Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.08 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including brain excitatory neurons; strongest in cone photoreceptor cells | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 2 Parkinson's papers of 78 | 0.85 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 3553
Sealed predictions
- SRRM4 in dopamine neurons, braak-0.07 (p 0.855) → +0.27 (p 0.485)receipt 3561
Swarm cases
receipt 3561: SRRM4 in dopamine neurons, braak
- power
- full sample +0.10 (p 0.696, n 18), 95% CI -0.39 to +0.54. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.11 (p 0.671, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.05 (p 0.854, n 18). could be the mix.
- skeptic
- leave-one-out range -0.00 to +0.24, sign flips 1; without severely affected donors +0.10 (p 0.696, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SRRM4 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts